It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

It may be possible to collect nearly three times as many stem cells for gene therapy for sickle cell disease (SCD) with ...

Myocardial infarction is a leading cause of death globally. Stem cell therapy is considered a potential treatment. Here, the authors propose an antioxidant polyurethane-based cardiac patch with ...

Cardiovascular diseases remain the leading cause of mortality globally, encompassing a range of disorders that affect the heart and blood vessels, including but not limited to ischemic heart disease, ...

Stem cells are specialized cells that have the potential to develop into not one but many different types of cell. They are unlike any other cell for three specific reasons: They are unspecialized, ...

Stem cell therapy is emerging as a promising solution for joint pain, offering regeneration and long-term relief by harnessing the body's natural healing abilities. Listen to Story Stem cell therapy ...

Department of Anesthesiology, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China Myocardial ischemia-reperfusion injury (MIRI) is a secondary injury caused by restoring blood ...

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a first-of-its-kind experimental therapy that has the potential to enhance heart ...

Microglia, the defense cells of the brain, are an integral component of the characteristic SVZ microenvironment and govern the behavior of the neural stem cells.

Sep. 26, 2020 — Researchers demonstrated a proof-of-concept stem cell treatment in a mouse model of Parkinson's disease. They found that neurons derived from stem cells can integrate well into ...

CULVER CITY, Calif., October 24, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that the first patients have been dosed in an initial trial ...

Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), Beijing 100005, China CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, National Center ...